1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEUROCRINE BIOSCIENCES, INC.
Neurocrine Biosciences, Inc. XNAS: NBIX
133.51 4.77 (3.71%)
1.3M
XNAS Volume

XNAS 09 Jul, 2025 5:30 PM (EDT)

Neurocrine Biosciences, Inc. - NBIX - stock price prediction, stock price target, analyst ratings from 25 analysts

Neurocrine Biosciences, Inc. has a share price target of US$ 160, revenue growth forecast of 14.2%, and profit growth estimate of 15.6% for FY25, based on top 25 analyst calls.